PAR paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-202

  1. 113 Posts.
    lightbulb Created with Sketch. 54
    Agreed, and continuing on the theme of rapid advances in AI, there is another reason to minimise time to market for a molecule that is off patent and protected predominantly by 'its a very well kept secret how we make it'. (look up DeepMind's progress with AlphaFold as an example)

    https://hotcopper.com.au/data/attachments/5184/5184346-fcbbb1085262a6dcecfc6fd2d40e0e05.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.010(2.44%)
Mkt cap ! $166.9M
Open High Low Value Volume
40.0¢ 42.0¢ 40.0¢ $168.2K 411.3K

Buyers (Bids)

No. Vol. Price($)
1 3500 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 50665 2
View Market Depth
Last trade - 16.11pm 18/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.